Alamar Biosciences, Inc.(ALMR.US)

Alamar Biosciences, Inc. operates as a proteomics company providing high-sensitivity protein biomarker analysis and precision proteomics solutions to support research and early disease detection. The company offers the NULISA proteomics platform for ultra-sensitive, multiplexed detection of protein biomarkers from small liquid biopsy specimens, and the ARGO HT system, a fully automated, high-throughput platform for biomarker profiling, validation, and clinical translation. Its services include integrated, cloud-based analytics, high-throughput sample processing, and pooled next-generation sequencing library preparation.